e‐TC: Development and pilot testing of a web‐based intervention to reduce anxiety and depression in survivors of testicular cancer

e‐TC is an online intervention designed to address common psychosocial concerns of testicular cancer survivors. It aims to reduce anxiety, depression and fear of cancer recurrence by providing evidence‐based information and psychological intervention. This paper details the development and pilot tes...

Full description

Saved in:
Bibliographic Details
Published in:European journal of cancer care 2017-11, Vol.26 (6), p.e12698-n/a
Main Authors: Heiniger, L.E., Smith, A.B., Olver, I., Grimison, P., Klein, B., Wootten, A., Abbott, J.‐A.M., Price, M.A., McJannett, M., Tran, B., Stockler, M.R., Gurney, H., Butow, P.N.
Format: Article
Language:English
Subjects:
Acceptability
Adult
Anxiety
Anxiety - psychology
Anxiety - therapy
Cancer
Cancer Survivors - psychology
Cognitive Therapy - methods
depression
Depression - psychology
Depression - therapy
fear of cancer recurrence
Feasibility
Feasibility Studies
Feedback
Health psychology
Health risk assessment
Humans
Internet
Intervention
Male
Men
Mens health
Mental depression
Middle Aged
Nursing
online intervention
Patient Acceptance of Health Care
Pilot Projects
Psychotherapy
Quantitative analysis
Stress, Psychological - psychology
Stress, Psychological - therapy
Survivor
survivors
Testes
Testicular cancer
Testicular Neoplasms - psychology
Therapy, Computer-Assisted - methods
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:e‐TC is an online intervention designed to address common psychosocial concerns of testicular cancer survivors. It aims to reduce anxiety, depression and fear of cancer recurrence by providing evidence‐based information and psychological intervention. This paper details the development and pilot testing of e‐TC. During pilot testing, 25 men (with varying psychological profiles) who had completed treatment for testicular cancer, 6 months to 5 years ago (which had not recurred), used e‐TC over a 10‐week period and provided quantitative and qualitative feedback on the feasibility and acceptability of the programme. Six men also completed a qualitative interview to provide detailed feedback on their experiences using e‐TC. Fourteen men (56%) completed at least 80% of the programme. Participants reported a high level of satisfaction with the programme. Men's limited time was a barrier to programme use and completion, and participants suggested that men with a more recent diagnosis and a higher level of distress may be more likely to engage with the programme. e‐TC appears to be a feasible and acceptable online intervention for survivors of testicular cancer. Findings from this study are currently being used to refine e‐TC and guide the design of a larger efficacy study.
ISSN:0961-5423
1365-2354
DOI:10.1111/ecc.12698